Novel medical composite material, preparation method thereof, and purpose thereof

A composite material and medicine technology, applied in the field of medicine, can solve the problems of low skin penetration rate, toxic and side effects, and side effects, and achieve the effect of improving non-nutritive chronic diseases and improving the quality of life

Inactive Publication Date: 2012-05-09
杨孟君
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Traditional drug treatment preparations have unavoidable toxic side effects
Various transdermal patches invented in recent years use a large number of materials that promote skin penetration and have side effects on the human body. At the same time, not only the skin penetration rate is not high, but also the skin is pasted with adhesives one to several times a day, which is difficult to avoid damage to the skin
It can synergize the functions of acupuncture and drug therapy, overcome the defects of acupuncture and drug therapy, and obtain new medical materials and new devices with a higher "treatment window" than acupuncture or drug therapy alone. invention

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel medical composite material, preparation method thereof, and purpose thereof
  • Novel medical composite material, preparation method thereof, and purpose thereof
  • Novel medical composite material, preparation method thereof, and purpose thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Using conventional polyurethane perfusion equipment, raw materials were weighed by weight percentage: 75% of polyurethane raw material, 10% of tourmaline powder, 5% of vanillyl nonanoic acid (70% content) and 10% of cidipril drug raw material. According to the general production process of polyurethane, the materials are put into the material tank, stirred and mixed evenly at high speed, the temperature and pouring flow are controlled by automatic production equipment, injected into the mold, heated (190°C) and matured, and pressed into a product with a diameter of 3cm, a thickness of 0.3cm, and a weight of 3 grams. Circular chip for clinical application.

[0031] Clinical test data:

[0032] The clinical effect of the product of the present invention is as follows through the First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, China's National Pharmacological Clinical Trial Base:

[0033] 1. Selection of subjects

[0034] 1.1 Age between 20...

Embodiment 2

[0075] Take 7 kg of medical silica gel raw material, 1.5 kg of tourmaline powder, 0.5 kg of nonanoic acid vanillic acid amide (70% content), 1 kg of sibutramine raw material, first put the medical silica gel raw material into the rubber mixing machine for refining, and then add tourmaline powder , nonanoic acid vanillylamide and sibutramine raw materials are mixed together to make them fully mixed and melted, and then put into the curing machine for curing, the curing temperature is 60 ° C, and stamped with a mold to form each with a diameter of 3 cm, a thickness of 0.3 cm, and a weight of 3 cm. The round chip of 1 gram is cooled and solidified for clinical application.

[0076] Clinical test data:

[0077] The clinical effect of the product of the present invention is clinically verified by the First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, China National Pharmacological Clinical Trial Base, and the results are as follows:

[0078] 1. Selectio...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of medicine, and specifically relates to a novel medical composite material with dual functions of acupuncture therapy and medicine therapy. The novel medical composite material is composed of 1-30% of tourmaline powder, 0.01-20% of a mediate-enhanced material, 1-20% of a raw material medicine, and 30-80% of a substrate. The material can be produced into passive medical instruments and devices, and other medical supplies, textiles and commodities. With the material, various diseases can be effectively treated. The material can be widely applied in the fields of human body healthcare treatments and rehabilitation.

Description

technical field [0001] The invention belongs to the field of medicine, and relates to a composite medical material and device with dual functions of acupuncture and drug therapy, and also relates to a preparation method and application of the material. Background technique [0002] Acupuncture and moxibustion is a medical technology with definite curative effect recognized all over the world, but traditional acupuncture tools have obvious defects. Acupuncture and moxibustion metal needles cause severe trauma and pain, and there are risks of cross-infection and medical risks of stabbing viscera when the needles penetrate the skin; traditional moxibustion tools need to use fire or electric combustion moxibustion material to heat the acupoints, which may burn the acupoints For the skin, each operation is very troublesome and harmful to the convolution of heterogeneous energy. Traditional drug treatment preparations have unavoidable toxic side effects. Various transdermal patc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61L31/02A61L31/00A61L31/16
Inventor 杨孟君杨哲
Owner 杨孟君
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products